Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Sky One Medical, a pharmaceutical company producing over-the-counter drugs in the People's Republic of China (PRC), has reported that its Tian Long Pharmaceutical Company (Tian Long) subsidiary, has obtained renewal of its good manufacturing practices certificate for pharmaceutical products (GMP Certificate) from the State Food and Drug Administration (SFDA) in China.
Subscribe to our email newsletter
China Sky One Medical said that the new certificate will be valid until May 2015.
Reportedly, SFDA’s examination committee had visited Tian Long in April to review its supply chain management practices, including quality control system test, inspect its GMP management process, production records for its five production lines, quality test record and laboratory management.
Yan-qing Liu, chairman and CEO of China Sky One Medical, said: “Given the extensive scope of the inspection and examination, we are very proud to pass the examination in just one round and successfully renewed the GMP Certificate for Tian Long.
“China Sky One Medical has built a solid track record of adhering to the highest quality control standards, thanks to our talented and dedicated executives and professional teams in the quality control and production departments.”